Zobrazeno 1 - 6
of 6
pro vyhledávání: '"O. I. Zvonareva"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 133-139 (2021)
The article presents the history of the study and registration in the USSR of the buccal form of nitroglycerin (trinitrolong) in the 1970s and 1980s, based on a number of author's publications, documentary evidence and oral stories of participants in
Externí odkaz:
https://doaj.org/article/ab25baa9d8084937a24582dce99dc305
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 977-983 (2020)
Aim. Based on the data of the TRUST study (Influence of Participation in Randomized Controlled Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor) to assess the quality of drug therapy and patients' awareness of achieving targe
Externí odkaz:
https://doaj.org/article/7a9dc1bd23584b428fa3ca606781823d
Autor:
N. O. Vasyukova, Yu. V. Lukina, O. I. Zvonareva, V. P. Voronina, S. N. Tolpygina, N. A. Dmitrieva, O. V. Lerman, A. V. Zagrebelny, I. V. Budaeva, E. S. Nekoshnova, N. P. Kutishenko, S. Yu. Martsevich
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 18, Iss 6, Pp 107-112 (2019)
Aim. To study the adherence to medication and visits in healthcare facilities and to assess some parameters of the treatment quality among patients who previously participated in randomized controlled trials (RCT).Material and methods. The TRUST (Inf
Externí odkaz:
https://doaj.org/article/7cf3de03a77d4676938a51b3c423a7e8
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 4, Pp 546-552 (2019)
Aim. To describe the design of TRUST study (Influence of Participation in Randomized Controlled Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor) and present the first part of this study to determine the motives of patient pa
Externí odkaz:
https://doaj.org/article/85caa0ac0c0b4c6eae087cf56d1d1e97
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 386-392 (2019)
The article focuses on the problem of low adherence to treatment among patients, in general, and provides data on the high adherence among patients in randomized controlled trials. Low adherence remains one of the most debated and difficult problems
Externí odkaz:
https://doaj.org/article/70a37f87608d42f69adbcb04aa0f9a19
Autor:
O. I. Zvonareva, E. S. Kulikov, I. A. Deev, O. S. Kobyakova, O. S. Fedorova, N. A. Kirillova, E. A. Starovoytova, N. G. Zhukova, I. A. Zhukova, V. V. Esip, E. D. Schastnyy, N. V. Khurkhurova, L. Yu. Nikitina, T. S. Golosova, I. D. Pimenov, M. A. Netaeva, S. V. Fedosenko
Publikováno v:
Бюллетень сибирской медицины, Vol 15, Iss 4, Pp 40-51 (2016)
Introduction. Currently, clinical trials (CT) remain the only technology, which provides proof of efficacy and safety of new drugs and their subsequent release to the market. Medical researcher and informed consent (IC) are the main (and often the on
Externí odkaz:
https://doaj.org/article/460c20e96e9a4c0aa94d31a4c3c9eb6a